share_log

Merrimack Pharmaceuticals(MACK.US):2024年Q1财报实现营收0美元,前值为0美元;每股收益为-0.03美元,前值为-0.02美元。

Zhitong Finance ·  May 16 04:45

Merrimack Pharmaceuticals(MACK.US):2024年Q1财报实现营收0美元,前值为0美元;每股收益为-0.03美元,前值为-0.02美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment